This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
GAPDH monoclonal antibody, clone BH-7
catalog :
MAB20072
quantity :
100 uL
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
BH-7
reactivity :
human
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry
product information
catalog id :
MAB20072
product name :
GAPDH monoclonal antibody, clone BH-7
product description :
Rabbit monoclonal antibody raised against synthetic peptide of human GAPDH.
clone name :
BH-7
isotype :
IgG
gene name :
GAPDH
gene alias :
G3PD GAPD MGC88685
gene description :
glyceraldehyde-3-phosphate dehydrogenase
immunogen :
A synthetic peptide corresponding to human GAPDH.
protein accession :
P04406
form :
Liquid
recommend dilutions :
Flow Cytometry (1:50). Immunocytochemistry (1:100-1:250). Immunofluorescence (1:100-1:250). Immunohistochemistry (1:100-1:500). Immunoprecipitation (1:50). Western Blot (1:3000-1:10000). The optimal working dilution should be determined by the
storage buffer :
In PBS, 150 mM NaCl, pH 7.4 (50% glycerol, 0.02% sodium azide).
storage instruction :
Store at -20 C for one year. After reconstitution, at 4 C for one month. It can also be aliquotted and stored frozen at -20 C for a longer time. Avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Rabbit
antigen species target species :
Human
species reactivity cross reactivity :
Human
application key :
Flow Cyt,IF,IHC,ICC,IP,WB
size :
100 uL
autodate :
11/30/18
updatetime :
7/22/21 13:20
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments